Iqvia (IQV) revenue: $16.3B
Iqvia reported $16.3B of revenue for the year ended Dec 31, 2025, up 5.9% from $15.4B a year earlier.
From Iqvia's filings with the SEC · Read the filing · IQV stock page
Iqvia revenue by year
#285 of 3,622 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $16.3B | +6% |
| Dec 31, 2024 | $15.4B | +3% |
| Dec 31, 2023 | $15B | +4% |
| Dec 31, 2022 | $14.4B | +4% |
| Dec 31, 2021 | $13.9B | – |
Revenue of similar companies
Companies in the same industry as Iqvia, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Iqvia | $16.3B | Dec 31, 2025 |
| Icon | $8.3B | Dec 31, 2025 |
| Incyte | $5.1B | Dec 31, 2025 |
| Charles River Laboratories International | $4B | Dec 27, 2025 |
| Medpace Holdings | $2.5B | Dec 31, 2025 |
| OmniAb | $18.7M | Dec 31, 2025 |
| Absci | $2.8M | Dec 31, 2025 |
Questions and answers
What is Iqvia's revenue?
Iqvia reported $16.3B of revenue for the year ended Dec 31, 2025, up 5.9% from $15.4B a year earlier.
Numbers as reported in Iqvia's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology